Kisqali

Ribociclib

7.3 High risk

Kisqali & Neutropenia

6.5%

of users reported Neutropenia

91.4%

also reported Severe reaction

99.8%

are women

Most common medical consequences

Severe reaction
91.4%
Hospitalization
3.7%
Life-threatening condition
3.6%
Death
1.2%
Disability
0.2%
Medical Intervention
<0.1%

Have you experienced any negative side effects from this medication?

Kisqali: general information

Most common side effects (321)

Most commonly affected ages

20 - 29 years
0.2%
30 - 39 years
5.7%
40 - 49 years
14.6%
50 - 59 years
21.5%
60 - 69 years
29.2%
70 - 79 years
23.0%
80 - 89 years
5.7%